Fluorine Substitution Can Block CYP3A4 Metabolism-Dependent Inhibition: Identification of (<i>S</i>)<i>-N</i>-[1-(4-Fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl)acrylamide as an Orally Bioavailable KCNQ2 Opener Devoid of CYP3A4 Metabolism-Dependent InhibitionYong‐Jin Wu, Michael Sinz, Ronald J. Knox et al.|Journal of Medicinal Chemistry|2003Cited by 59
Population pharmacokinetics and pharmacogenetics analyses of imatinib in Chinese patients with chronic myeloid leukemia in a real-world situationShiyu He, Qian Jiang, Qian-Hang Shao et al.|Cancer Chemotherapy and Pharmacology|2023Cited by 7
Population Pharmacokinetics and Pharmacogenetics Analyses of Dasatinib in Chinese Patients with Chronic Myeloid LeukemiaShiyu He, Qian Jiang, Jinxia Zhao et al.|Pharmaceutical Research|2023Cited by 5